Tag: BioNTech
BioNTech-Pfizer Bispecific Antibody Shows Promise in Advanced Lung Cancer at ASCO 2026
BioNTech and Pfizer's experimental bispecific antibody BNT327 showed promising activity in advanced lung cancer patients at ASCO 2026. The dual-pathway…
Submit Your Paper to GMJ
No APC until January 2027.